| [1] |
ZHANG L, ZHAO M H, ZUO L, et al. China Kidney Disease Network (CK-NET) 2016 Annual Data Report [J]. Kidney Int Suppl, 2020, 10(2): e97-e185. doi:10.1016/j.kisu.2020.09.001
doi: 10.1016/j.kisu.2020.09.001
|
| [2] |
COHEN-HAGAI K, NACASCH N, STERNSCHUSS A, et al. Malnutrition and inflammation in hemodialysis patients: Comparative evaluation of neutrophil reactive oxygen formation [J]. Nutrition, 2020, 78: 110793. doi:10.1016/j.nut.2020.110793
doi: 10.1016/j.nut.2020.110793
|
| [3] |
RAHMAN T, KHOR B H, SAHATHEVAN S, et al. Protein Energy Wasting in a Cohort of Maintenance Hemodialysis Patients in Dhaka, Bangladesh [J]. Nutrients, 2022, 14(7)1408. doi:10.3390/nu14071469
doi: 10.3390/nu14071469
|
| [4] |
KALANTAR-ZADEH K, KOPPLE J D, BLOCK G, et al. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients [J]. Am J Kidney Dis, 2001, 38(6): 1251-1263. doi:10.1053/ajkd.2001.29222
doi: 10.1053/ajkd.2001.29222
|
| [5] |
陈璐琳, 杨廷杰, 孙猛,等. 营养不良与冠状动脉炎症对冠心病患者预后的影响 [J]. 实用医学杂志, 2025, 41(7): 1010-1017.
|
| [6] |
母元梅, 赵佳圆, 张莹. C反应蛋白/白蛋白比值与维持性血液透析患者心血管事件风险的关系 [J]. 实用医学杂志, 2024, 40(1): 72-78.
|
| [7] |
VALENTE M J, ROCHA S, COIMBRA S, et al. Long Pentraxin 3 as a Broader Biomarker for Multiple Risk Factors in End-Stage Renal Disease: Association with All-Cause Mortality [J]. Mediators Inflamm, 2019, 2019: 3295725. doi:10.1155/2019/3295725
doi: 10.1155/2019/3295725
|
| [8] |
DONI A, MANTOVANI A, BOTTAZZI B, et al. PTX3 Regulation of Inflammation, Hemostatic Response, Tissue Repair, and Resolution of Fibrosis Favors a Role in Limiting Idiopathic Pulmonary Fibrosis [J]. Front Immunol, 2021, 12: 676702. doi:10.3389/fimmu.2021.676702
doi: 10.3389/fimmu.2021.676702
|
| [9] |
SUH S H, OH T R, CHOI H S, et al. Predictive Value of Serum Hepcidin Levels for the Risk of Incident End-Stage Kidney Disease in Patients with Chronic Kidney Disease: The KNOW-CKD [J]. Kidney Dis (Basel), 2024, 10(6): 492-503.
|
| [10] |
ZOU L X, SUN L, HUA R X, et al. Serum Hepcidin-25 and All-Cause Mortality in Patients Undergoing Maintenance Hemodialysis [J]. Int J Gen Med, 2021, 14: 3153-3162. doi:10.2147/ijgm.s313777
doi: 10.2147/ijgm.s313777
|
| [11] |
XU Y, WANG Y, HU H, et al. Relationship between serum hepcidin levels and cardiovascular disease in patients with maintenance hemodialysis [J]. Physiol Int, 2020, 107(4): 491-500. doi:10.1556/2060.2020.00040
doi: 10.1556/2060.2020.00040
|
| [12] |
FENG T, XU Y, ZHENG J, et al. Prevalence of and risk factors for chronic kidney disease in ten metropolitan areas of China: A cross-sectional study using three kidney damage markers [J]. Ren Fail, 2023, 45(1): 2170243. doi:10.1080/0886022x.2023.2170243
doi: 10.1080/0886022x.2023.2170243
|
| [13] |
董朝坤, 翁敏. 生物电阻抗相位角在维持性血液透析患者营养状况中的研究进展 [J]. 实用医学杂志, 2022, 38(9): 1157-1160.
|
| [14] |
CARRERO J J, THOMAS F, NAGY K, et al. Global Prevalence of Protein-Energy Wasting in Kidney Disease: A Meta-analysis of Contemporary Observational Studies From the International Society of Renal Nutrition and Metabolism [J]. J Ren Nutr, 2018, 28(6): 380-392. doi:10.1053/j.jrn.2018.08.006
doi: 10.1053/j.jrn.2018.08.006
|
| [15] |
MORAIS D M, TROMBIM I C, DE G ES C R, et al. The adductor pollicis muscle thickness is not associated with physical function, lean mass, and nutritional status in patients on maintenance hemodialysis [J]. Front Nutr, 2024, 11: 1502309. doi:10.3389/fnut.2024.1502309
doi: 10.3389/fnut.2024.1502309
|
| [16] |
TUR K, G L A. Independent Association Between Malnutrition Inflammation Score and C Reactive Protein/Albumin Ratio in Hemodialysis Patients [J]. J Inflamm Res, 2024, 17: 9325-9333. doi:10.2147/jir.s477307
doi: 10.2147/jir.s477307
|
| [17] |
TAKAHASHI H, INOUE K, SHIMIZU K, et al. Comparison of Nutritional Risk Scores for Predicting Mortality in Japanese Chronic Hemodialysis Patients [J]. J Ren Nutr, 2017, 27(3): 201-206. doi:10.1053/j.jrn.2016.12.005
doi: 10.1053/j.jrn.2016.12.005
|
| [18] |
TOLEDO F R, ANTUNES A A, VANNINI F C D, et al. Validity of malnutrition scores for predicting mortality in chronic hemodialysis patients [J]. Int Urol Nephrol, 2013, 45(6): 1747-1752. doi:10.1007/s11255-013-0482-3
doi: 10.1007/s11255-013-0482-3
|
| [19] |
刘洁琼, 王景福. 老年维持性血液透析患者穿透素3与超敏C反应蛋白和营养不良的关系 [J]. 河北医科大学学报, 2019, 40(6): 654-657.
|
| [20] |
ROCHA S, VALENTE M J, COIMBRA S, et al. Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms-association with inflammation and all-cause mortality in end-stage-renal disease patients on dialysis [J]. Sci Rep, 2021, 11(1): 14768. doi:10.1038/s41598-021-94075-x
doi: 10.1038/s41598-021-94075-x
|
| [21] |
YILMAZ M I, SONMEZ A, ORTIZ A, et al. Soluble TWEAK and PTX3 in nondialysis CKD patients: Impact on endothelial dysfunction and cardiovascular outcomes [J]. Clin J Am Soc Nephrol, 2011, 6(4): 785-792. doi:10.2215/cjn.09231010
doi: 10.2215/cjn.09231010
|
| [22] |
TSAI H C, OU S M, WU C C, et al. Pentraxin 3 Predicts Arteriovenous Fistula Functional Patency Loss and Mortality in Chronic Hemodialysis Patients [J]. Am J Nephrol, 2022, 53(2/3): 148-156. doi:10.1159/000522049
doi: 10.1159/000522049
|
| [23] |
LI H, MALHOTRA S, KUMAR A. Nuclear factor-kappa B signaling in skeletal muscle atrophy [J]. J Mol Med (Berl), 2008, 86(10): 1113-1126. doi:10.1007/s00109-008-0373-8
doi: 10.1007/s00109-008-0373-8
|
| [24] |
MIYAMOTO T, RASHID QURESHI A, HEIMB RGER O, et al. Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal disease [J]. Clin J Am Soc Nephrol, 2011, 6(12): 2785-2791. doi:10.2215/cjn.02320311
doi: 10.2215/cjn.02320311
|
| [25] |
FOUQUE D, KALANTAR-ZADEH K, KOPPLE J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease [J]. Kidney Int, 2008, 73(4): 391-398. doi:10.1038/sj.ki.5002585
doi: 10.1038/sj.ki.5002585
|
| [26] |
ISOYAMA N, QURESHI A R, AVESANI C M, et al. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients [J]. Clin J Am Soc Nephrol, 2014, 9(10): 1720-1728. doi:10.2215/cjn.10261013
doi: 10.2215/cjn.10261013
|
| [27] |
GANZ T. Systemic iron homeostasis [J]. Physiol Rev, 2013, 93(4): 1721-1741. doi:10.1152/physrev.00008.2013
doi: 10.1152/physrev.00008.2013
|
| [28] |
MALTANERI R E, CHAMORRO M E, GIONCO S E, et al. Erythropoietin enhances iron bioavailability in HepG2 cells by downregulating hepcidin through mTOR, C/EBPα and HIF-1α [J]. Biochim Biophys Acta Mol Cell Res, 2024, 1871(7): 119800. doi:10.1016/j.bbamcr.2024.119800
doi: 10.1016/j.bbamcr.2024.119800
|
| [29] |
张妍, 周晓玲, 陈孟华. 终末期肾脏病患者血清中铁调素的水平变化及其与铁代谢的关系 [J]. 中国血液净化, 2011, 10(7): 371-375.
|
| [30] |
MATSUOKA T, ABE M, KOBAYASHI H. Iron Metabolism and Inflammatory Mediators in Patients with Renal Dysfunction [J]. Int J Mol Sci, 2024, 25(7):3745. doi:10.3390/ijms25073745
doi: 10.3390/ijms25073745
|
| [31] |
GANGAT N, WOLANSKYJ A P. Anemia of chronic disease [J]. Semin Hematol, 2013, 50(3): 232-238. doi:10.1053/j.seminhematol.2013.06.006
doi: 10.1053/j.seminhematol.2013.06.006
|
| [32] |
CARRERO J J, STENVINKEL P, CUPPARI L, et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: A consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM) [J]. J Ren Nutr, 2013, 23(2): 77-90. doi:10.1053/j.jrn.2013.01.001
doi: 10.1053/j.jrn.2013.01.001
|
| [33] |
LI Y, YANG Y, WANG J. Skeletal muscle mass and kidney function among Chinese older adults: A cross-sectional study [J]. Ren Fail, 2024, 46(2): 2377776. doi:10.1080/0886022x.2024.2377776
doi: 10.1080/0886022x.2024.2377776
|